RxDoctor Payments Data

David Dick, MD

Family Medicine · Warsaw, INNPI 1609819606

Payments from drug & device makers

$1,970in general payments, 2019–2025

Across 122 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$407
  • Novo Nordisk$140
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$134
  • Novartis$132
  • AstraZeneca$84
  • Lilly USA, LLC$80
  • plus $993 from 30 others

What the payments were for

  • Food & beverage$1,970100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,970 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$58,980
Medicare patients
173
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin25$30,266
JanuviaSitagliptin Phosphate14$18,124
JanumetSitagliptin Phos/Metformin Hcl11$16,164
EliquisApixaban15$14,322
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$12,799
DuleraMometasone/Formoterol16$5,646
Losartan Potassium226$1,517
SynthroidLevothyroxine Sodium11$1,395
Atorvastatin Calcium269$1,349
Lisinopril187$1,318
Albuterol Sulfate HfaAlbuterol Sulfate60$1,247
Levothyroxine Sodium188$1,146
Rosuvastatin Calcium100$1,031
Ventolin HfaAlbuterol Sulfate17$869
Metoprolol Succinate98$822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Dulera$13$39,93441 claims
Boehringer IngelheimJardiance$14$30,26625 claims
PfizerEliquis$73$14,32215 claims
AbbVieSynthroid$407$1,39511 claims
Almatica Pharma LLCSertraline Hcl$16$28648 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Warsaw

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →